BPC-157 neuroprotective properties, demonstrated in multiple neurotoxicity models, suggest potential for both prevention and treatment of CIPN
The primary focus is on two alkyl cobalamins, methylcobalamin (MeCbl) and adenosylcobalamin (AdoCbl), as well as two non-alkyl cobalamins, cyanocobalamin (CNCbl) and hydroxocobalamin (HOCbl)
The most notable BPC-157 benefits are as follows: Gut Health Like its natural counterpart, BPC-157 is a powerful cytoprotective agent, stabilizing the GI lining and assisting in the prevention and repair of intestinal lesions
Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses
MOTS-c is typically administered via subcutaneous injection into the abdomen, lateral thigh, or flank, rotating injection sites to prevent tissue accumulation